(1)
BRAND EQUITY AND COUNTRY OF ORIGIN MODEL IN PHARMACEUTICAL INDUSTRY. AJBMR 2014, 3 (6), 137-146. https://doi.org/10.65453/ajbmr.v3i6.554.